GREAT POINT PARTNERS LLC Quant / Systematic

CIK: 0001281446 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value ($000): $413,781 (100.0% shares, 0.0% debt)

Holdings (30)

EXEL EXELIXIS INC 7.1%
Value ($000) $29,471 Shares 1,300,000 Est. Cost $21.47 Unrealized -9.0%
XENE XENON PHARMACEUTICALS INC 6.8%
Value ($000) $28,124 Shares 920,000 Est. Cost $20.67 Unrealized +44.8%
TVTX TRAVERE THERAPEUTICS INC 6.3%
Value ($000) $26,028 Shares 1,010,000 Est. Cost $25.28 Unrealized +5.0%
BCYC BICYCLE THERAPEUTICS PLC 5.8%
Value ($000) $24,160 Shares 550,592 Est. Cost $50.05 Unrealized
JAZZ JAZZ PHARMACEUTICALS PLC 5.8%
Value ($000) $24,129 Shares 155,000 Est. Cost $145.12 Unrealized 0.0%
CYTK CYTOKINETICS INC 5.8%
Value ($000) $23,927 Shares 650,000 Est. Cost $32.25 Unrealized +10.2%
CHINOOK THERAPEUTICS INC 5.6%
Value ($000) $23,291 Shares 1,423,682 Est. Cost $16.35 Unrealized
GLPG GALAPAGOS NV 5.4%
Value ($000) $22,327 Shares 360,000 Est. Cost $56.28 Unrealized
VRTX VERTEX PHARMACEUTICALS INC 5.4%
Value ($000) $22,182 Shares 85,000 Est. Cost $195.24 Unrealized +21.6%
PCVX VAXCYTE INC 5.2%
Value ($000) $21,376 Shares 885,153 Est. Cost $22.75 Unrealized -4.0%
RLMD RELMADA THERAPEUTICS INC 5.2%
Value ($000) $21,322 Shares 790,000 Est. Cost $22.09 Unrealized -6.4%
ANAB ANAPTYSBIO INC 4.2%
Value ($000) $17,318 Shares 700,000 Est. Cost $25.71 Unrealized +17.7%
POINT BIOPHARMA GLOBAL INC 4.0%
Value ($000) $16,418 Shares 2,060,000 Est. Cost $7.75 Unrealized
ACRS ACLARIS THERAPEUTICS INC 3.9%
Value ($000) $16,248 Shares 942,445 Est. Cost $15.39 Unrealized -11.4%
KALV KALVISTA PHARMACEUTICALS INC 3.1%
Value ($000) $12,886 Shares 874,197 Est. Cost $15.10 Unrealized -4.8%
RIGEL PHARMACEUTICALS INC 2.9%
Value ($000) $11,960 Shares 4,000,000 Est. Cost $3.25 Unrealized
KINIKSA PHARMACEUTICALS LTD 2.7%
Value ($000) $11,114 Shares 1,118,067 Est. Cost $10.66 Unrealized
TRICIDA INC 2.5%
Value ($000) $10,275 Shares 1,250,000 Est. Cost $4.49 Unrealized
RNAM AVIDITY BIOSCIENCES INC 2.2%
Value ($000) $9,235 Shares 500,000 Est. Cost $23.88 Unrealized -28.9%
SLN SILENCE THERAPEUTICS PLC 2.0%
Value ($000) $8,444 Shares 444,443 Est. Cost $23.89 Unrealized
URGN UROGEN PHARMA LTD 1.8%
Value ($000) $7,608 Shares 873,424 Est. Cost $15.60 Unrealized -50.0%
PIERIS PHARMACEUTICALS INC 1.6%
Value ($000) $6,663 Shares 2,199,076 Est. Cost $3.56 Unrealized
ARDX ARDELYX INC 1.2%
Value ($000) $5,095 Shares 4,761,905 Est. Cost $0.89 Unrealized 0.0%
VTYX VENTYX BIOSCIENCES INC 1.1%
Value ($000) $4,564 Shares 336,334 Est. Cost $13.36 Unrealized 0.0%
ABOS ACUMEN PHARMACEUTICALS INC 0.9%
Value ($000) $3,630 Shares 928,282 Est. Cost $5.44 Unrealized 0.0%
MAGENTA THERAPEUTICS INC 0.8%
Value ($000) $3,393 Shares 1,170,000 Est. Cost $9.65 Unrealized
CINCOR PHARMA INC 0.3%
Value ($000) $1,397 Shares 79,670 Est. Cost $17.53 Unrealized
NEKTAR THERAPEUTICS 0.1%
Value ($000) $539 Shares 100,000 Est. Cost Unrealized
PASSAGE BIO INC 0.1%
Value ($000) $353 Shares 113,900 Est. Cost $6.35 Unrealized
RFL RAFAEL HLDGS INC 0.1%
Value ($000) $304 Shares 121,000 Est. Cost $45.91 Unrealized -92.5%